Cytodyn Inc (CYDY)

[justdafactss]

Bags aint happy thats for sure. Leronsaline no better than placebo---

The CD10 trial results showed no clinically meaningful differences in average change in “total clinical symptom score” from baseline to Day 14 between study arms (-3.5 in the leronlimab group versus -3.4 in the placebo group). Additionally, none of the secondary endpoints were met in this study, including mortality, time to symptom resolution, and time to return to normal activity. Taken together, the CD10 results indicate that most study participants experienced resolution in COVID-19 symptoms regardless of whether they received leronlimab or placebo.

The larger trial that CytoDyn conducted in patients with severe COVID-19 disease (CD12) also failed to find any effect of the drug on the primary study endpoint, with no difference seen in mortality (20.5% in the leronlimab treatment group and 21.6% in the placebo treatment group); or on any of the secondary endpoints, for example, with no difference on the average length of hospitalization (21.4 days in both the leronlimab and the placebo treatment groups).
https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab

Hmmmm, any chance CYDY will be held accountable by the SEC and DOJ for the hundreds of PRs scrubbed from the CYDY website and dozens of video pumps?

A few here (one in particular) always bitching about "bashing" posts on message boards, lets see how that stacks up against PRs disseminated to the investment community via pay for play outlets like PR Newswire, GlobeNewswire, etc., etc.